SUPPRESSION OF PIGMENTATION IN MOUSE MELANOMA CELLS BY 5-BROMODEOXYURIDINE
Open Access
- 1 May 1973
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 57 (2), 406-423
- https://doi.org/10.1083/jcb.57.2.406
Abstract
Low concentrations (1-3 microg/ml) of 5-bromodeoxyuridine (BrdU) reversibly suppress pigmentation in a highly pigmented clone (B(5)59) of cultured B16 mouse melanoma cells. We have found that unpigmented cells (clone C(3)471), derived by long-term culture of B(5)59 cells in 1 microg of BrdU/ml, were completely amelanotic with no biochemically or cytochemically detectable tyrosinase activity or ultrastructural evidence of premelanosomes. The process by which pigmentation is suppressed was studied in B(5)59 cells during a 7-day period of growth with BrdU (3 microg/ml). Assays of tyrosinase activity showed that activity was reduced after 1 day and decreased progressively, approaching zero by 7 days. A quantitatively minor part of this reduction was directly attributable to the appearance of a dialyzable inhibitor of tyrosinase activity. Acrylamide gel electrophoresis revealed two bands of activity corresponding in Rx values to the T(1) and T(2) forms of soluble tyrosinase. Both were progressively reduced during growth with BrdU but one form (T(1)) was consistently affected earlier than the other (T(2)). Ultrastructural-cytochemical studies also showed an early effect on the localization of tyrosinase reaction product. At day 3, reaction product was no longer present in Golgi saccules and Golgi-associated smooth surfaced tubules, but was still seen within premelanosomes, compound melanosomes, and occasional Golgi-associated vesicles. By 7 days tyrosinase reaction product was usually not demonstrable. The number of premelanosomes was progressively decreased during growth with BrdU. Premelanosomes became concentrated in the juxtanuclear region and at day 3 many were contained within abnormally large and numerous compound melanosomes. Premelanosomes and compound melanosomes were rarely seen at 7 days, by which time the cultures were nearly amelanotic. The coordinated suppression of melanogenesis by BrdU may provide a useful model in which to study the normal regulation of this process.Keywords
This publication has 37 references indexed in Scilit:
- PROTEIN TRANSPORT IN MOUSE KIDNEY UTILIZING TYROSINASE AS AN ULTRASTRUCTURAL TRACERThe Journal of Experimental Medicine, 1972
- Inhibition of mucopolysaccharide synthesis by 5-bromodeoxyuridine in cultures of chick amnion cellsDevelopmental Biology, 1971
- Preferential inhibition by 5-bromodeoxyuridine of the synthesis of tyrosine aminotransferase in hepatoma cell culturesJournal of Molecular Biology, 1971
- A Study of the Mechanism of Action and Role of a Natural Inhibitor of Dopa Autoxidation isolated from Guinea Pig Skin**From the Skin Biochemistry Section, Unilever Research Laboratory, Isleworth Middlesex, EngLand.Journal of Investigative Dermatology, 1970
- CONTROL OF PIGMENT PRODUCTION IN MOUSE MELANOMA CELLS IN VITROThe Journal of cell biology, 1969
- Golgi-melanosome relationship in human melanoma in vitroJournal of Ultrastructure Research, 1969
- ULTRASTRUCTURAL AND CYTOCHEMICAL OBSERVATIONS ON B-16 AND HARDING-PASSEY MOUSE MELANOMAS THE ORIGIN OF PREMELANOSOMES AND COMPOUND MELANOSOMESJournal of Histochemistry & Cytochemistry, 1968
- Tyrosinase Inhibitor in Fortner's Amelanotic and Melanotic Malignant Melanoma*Journal of Investigative Dermatology, 1967
- Sulfhydryl Content in Subcellular Fractions of Mouse MelanomasJournal of Investigative Dermatology, 1967
- Tyrosinase Inhibition: Its Role in Suntanning and in AlbinismScience, 1967